Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
Sales | 68 | 45 | 0 | 5,000 | 5,000 |
Gross Profit | 68 | 45 | N/A | 5,000 | 5,000 |
Operating Expenses | 2,403 | 2,424 | 2,476 | 2,190 | 3,120 |
Operating Income | -2,335 | -2,379 | -2,476 | 2,810 | 1,880 |
Interest Expense | 5 | 12 | 7 | 10 | 20 |
Other Income | 174 | 4,447 | 156 | 220 | 50 |
Pre-tax Income | -2,166 | 2,056 | -2,327 | 3,020 | 1,910 |
Income Tax | N/A | N/A | -177 | 0 | 0 |
Net Income Continuous | -2,166 | 2,056 | -2,150 | 3,026 | 1,912 |
Net Income | $-2,166 | $2,056 | $-2,150 | $3,026 | $1,912 |
EPS Basic Total Ops | -9,497.35 | 8,705.91 | -9,497.35 | 13,454.57 | 8,310.23 |
EPS Basic Continuous Ops | -9,360.91 | 8,884.03 | -9,379.46 | 15,130.00 | 9,560.00 |
EPS Diluted Total Ops | -9,497.35 | 8,705.91 | -9,497.35 | 13,058.97 | 8,310.23 |
EPS Diluted Continuous Ops | -9,360.91 | 8,856.24 | -9,379.46 | 15,130.00 | 9,560.00 |
EBITDA(a) | $-2,247 | $-2,274 | $-2,364 | $2,930 | $1,890 |